This Week's CGT News: World's First Solid Tumor CAR T Approved in China
06/30/2026
5 min read
News
False
Advertisement
Related Content
Biopharma
Industry News
Development & Clinical
Phase III Success Marks Milestone for Personalized Cancer Vaccines
August 26, 2026
7 min read
Merck and Moderna report positive phase III results for intismeran in melanoma, as The Medicine Maker revisits how cancer vaccines work and the challenges still facing the field
Cell & Gene
Industry News
Research News
This Week’s CGT News: Antifreeze Sugars Protect CAR T Cells
August 24, 2026
5 min read
A new preservation method could remove a major barrier to treatment, the FDA approves the first gene therapy for GSDIa, and ultrasound directs CAR T cells toward solid tumors
Cell & Gene
Industry News
Research News
This Week’s CGT News: T-Cell Therapy Clears Pediatric Solid Tumor
August 17, 2026
3 min read
PRAME-targeted T cells produce a complete response in metastatic nephroblastoma, CAR T cells remain active after a decade, and an in vivo CRISPR screen identifies edits that strengthen solid-tumor activity
Cell & Gene
Industry News
Research News
This Week’s CGT News: In Vivo CAR T Draws Major Investment
August 10, 2026
3 min read
Johnson & Johnson partners with Sail Biomedicines, an FDA advisory committee votes against deramiocel for Duchenne cardiomyopathy, and researchers uncover factors influencing CAR T and CAR NK outcomes